ARCHIVES

In Brief: James Downing named CEO of St. Jude

This article is from The Cancer Letter archive.

Vol. 40 No. 26 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Advisory Group, Other Cancer Meeting

May 26, 1978

In Brief: NCI Seeks Better Ways to Make Available Fresh Tissue; Iverson Heads Cancer Control Science

October 5, 1984

In Breif: Baltimore Developer Donates $10 Million To Univ. of Maryland Medical System

July 19, 1996

“If We Had More Resources, It’s A Fantastic Time” For Cancer Research

May 12, 1995

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

January 25, 2013

NCI Considers Making Prevention Trial From NSABP; Other Groups Approached

May 13, 1994